KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial
Hlavní autoři: | , , , , , , , , , , , , , , , |
---|---|
Médium: | Conference item |
Vydáno: |
2012
|
Shrnutí: |
---|